Related Experiment Video
Updated: Jan 25, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Pharmacological Modulation of Transcriptional Coregulators in Cancer
Timothy R Bishop1, Yuxiang Zhang1, Michael A Erb1
1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Upon binding of transcription factors to cis-regulatory DNA sequences, transcriptional coregulators are required for the activation or suppression of chromatin-dependent transcriptional signaling. These coregulators are frequently implicated in oncogenesis via causal roles in dysregulated, malignant transcriptional control and represent one of the fastest-growing target classes in small-molecule drug discovery. However, challenges in targeting coregulators include identifying evidence of cancer-specific genetic dependency, matching the pharmacologically addressable protein fold to a functional role in disease pathology, and achieving the necessary selectivity to exploit a given genetic dependency. We discuss here how recent trends in cancer pharmacology have confronted these challenges, positioning coregulators as tractable targets in the development of new cancer therapies.
Insights
Transcriptional coregulators regulate gene expression and are key in cancer development. Recent advances in cancer pharmacology are making these proteins viable targets for new small-molecule cancer drugs.
Area of Science:
- Molecular Biology
- Cancer Biology
- Pharmacology
Background:
- Transcriptional coregulators are essential for gene regulation by transcription factors.
- These proteins play critical roles in oncogenesis through aberrant control of gene transcription.
- Coregulators are a rapidly expanding target class in small-molecule drug discovery for cancer.
Purpose of the Study:
- To review challenges and recent trends in targeting transcriptional coregulators in cancer therapy.
- To highlight the potential of coregulators as tractable targets for novel cancer drug development.
Main Methods:
- Review of recent trends in cancer pharmacology.
- Discussion of challenges in targeting transcriptional coregulators.
- Analysis of the role of coregulators in cancer-specific genetic dependencies and disease pathology.
Main Results:
- Identifying cancer-specific genetic dependencies for coregulator targeting remains a challenge.
- Matching pharmacologically relevant protein folds to disease pathology is crucial.
- Achieving selectivity is necessary to exploit genetic dependencies.
Conclusions:
- Recent trends in cancer pharmacology are addressing challenges in targeting transcriptional coregulators.
- Coregulators are increasingly recognized as tractable targets for developing new cancer therapies.
- Small-molecule drug discovery targeting coregulators shows promise for future cancer treatments.
More Related Videos
Related Concept Videos
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Transcription Factors
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...

